Radical Surgery Improves Survival in Patients with Stage 4 Neuroblastoma
- PMID: 29127465
- DOI: 10.1007/s00268-017-4340-9
Radical Surgery Improves Survival in Patients with Stage 4 Neuroblastoma
Abstract
Background: Neuroblastoma (NBL) is the most common extracranial solid tumor in children. Despite a good overall prognosis in NBL patients, the outcome of children with stage 4 disease, even with multimodal intensive therapy, remains poor. The role of extended surgical resection of the primary tumor is in numerous studies controversial. The aim of this study was to retrospectively analyze the impact of radical surgical resection on the overall- and event-free survival of stage 4 NBL patients.
Methods: We retrospectively analyzed patient charts of 40 patients with stage 4 NBL treated in our institution between January 1990 and May 2012. All clinical and pathological findings of stage 4 NBL patients were included. Extent of surgery was assessed from the operation records and was classified as non-radical (tumor biopsy, partial 50-90% resection) or radical (near-complete >90% resection, complete resection). Overall- (OS) and event-free (EFS) survival was assessed using the Kaplan-Meier analysis and log-rank test. A multivariate Cox regression analysis was used to demonstrate independency.
Results: In total, 29/40 patients were operated radically (>90% resection), whereas 11 patients received subtotal resection or biopsy only. OS and EFS were significantly increased in patients with radical operation compared with non-radical resection (p = 0.0003 for OS, p = 0.004 for EFS; log-rank test). A multivariate Cox regression analysis revealed radical operation as a significant and independent parameter for OS and EFS.
Conclusions: Our data indicate that radical (over 90% resection) surgery improves OS and EFS in stage 4 NBL patients.
Similar articles
-
Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.BMC Cancer. 2017 Aug 4;17(1):520. doi: 10.1186/s12885-017-3493-0. BMC Cancer. 2017. PMID: 28778185 Free PMC article.
-
Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy.J Pediatr Surg. 2014 Apr;49(4):528-33. doi: 10.1016/j.jpedsurg.2013.11.061. Epub 2013 Dec 1. J Pediatr Surg. 2014. PMID: 24726106
-
Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis.J Clin Oncol. 2013 Feb 20;31(6):752-8. doi: 10.1200/JCO.2012.45.9339. Epub 2013 Jan 2. J Clin Oncol. 2013. PMID: 23284039
-
Role of surgery in localized initially unresectable neuroblastoma.J Pediatr Urol. 2018 Jun;14(3):231-236. doi: 10.1016/j.jpurol.2018.03.008. Epub 2018 Mar 31. J Pediatr Urol. 2018. PMID: 29636298 Review.
-
Impact of extent of resection on survival in high-risk neuroblastoma: A systematic review and meta-analysis.J Pediatr Surg. 2019 Jul;54(7):1487-1494. doi: 10.1016/j.jpedsurg.2018.08.046. Epub 2018 Sep 6. J Pediatr Surg. 2019. PMID: 30262202
Cited by
-
Surgical Excision of an Adrenal Neuroblastoma in a Dog.Front Vet Sci. 2019 May 29;6:161. doi: 10.3389/fvets.2019.00161. eCollection 2019. Front Vet Sci. 2019. PMID: 31214604 Free PMC article.
-
Anti-GD2-IRDye800CW as a targeted probe for fluorescence-guided surgery in neuroblastoma.Sci Rep. 2020 Oct 19;10(1):17667. doi: 10.1038/s41598-020-74464-4. Sci Rep. 2020. PMID: 33077751 Free PMC article.
-
Establishment and validation of a nomogram to predict cancer-specific survival in pediatric neuroblastoma patients.Front Pediatr. 2023 Mar 3;11:1105922. doi: 10.3389/fped.2023.1105922. eCollection 2023. Front Pediatr. 2023. PMID: 36937951 Free PMC article.
-
Clinical Characteristics and Survival Outcomes in Neuroblastoma With Bone Metastasis Based on SEER Database Analysis.Front Oncol. 2021 Jun 1;11:677023. doi: 10.3389/fonc.2021.677023. eCollection 2021. Front Oncol. 2021. PMID: 34141621 Free PMC article.
-
Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma.Front Immunol. 2023 Apr 4;14:1135617. doi: 10.3389/fimmu.2023.1135617. eCollection 2023. Front Immunol. 2023. PMID: 37081871 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical